Chemoinformaics analysis of HEXADECANEDIOIC ACID
| Molecular Weight | 286.412 | nRot | 15 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 9 |
| Exact Molecular Weight | 286.214 | nRing | 0 |
| Solubility: LogS | -4.098 | nHRing | 0 |
| Solubility: LogP | 4.54 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 49.9318 |
| nHD | 2 | BPOL | 31.8322 |
| QED | 0.551 |
| Synth | 4.203 |
| Natural Product Likeliness | 2.578 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.776 |
| Pgp-sub | 0 |
| HIA | 0.015 |
| CACO-2 | -4.555 |
| MDCK | 0.0000208 |
| BBB | 0.834 |
| PPB | 0.853657 |
| VDSS | 1.85 |
| FU | 0.136759 |
| CYP1A2-inh | 0.112 |
| CYP1A2-sub | 0.217 |
| CYP2c19-inh | 0.204 |
| CYP2c19-sub | 0.902 |
| CYP2c9-inh | 0.244 |
| CYP2c9-sub | 0.38 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.426 |
| CYP3a4-inh | 0.692 |
| CYP3a4-sub | 0.374 |
| CL | 3.926 |
| T12 | 0.138 |
| hERG | 0.013 |
| Ames | 0.003 |
| ROA | 0.014 |
| SkinSen | 0.143 |
| Carcinogencity | 0.117 |
| EI | 0.682 |
| Respiratory | 0.896 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.57311 |